PolyPid
PYPD
33 hedge funds and large institutions have $16.7M invested in PolyPid in 2026 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 0 closing their positions.
74% more funds holding
Funds holding: 19 → 33 (+14)
22% more capital invested
Capital invested by funds: $13.7M → $16.7M (+$3.01M)
0.86% more ownership
Funds ownership: 16.34% → 17.2% (+0.86%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
87% less call options, than puts
Call options by funds: $15K | Put options by funds: $119K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$530K |
| 2 |
Renaissance Technologies
New York
|
+$452K |
| 3 |
QC
Quadrature Capital
London,
United Kingdom
|
+$327K |
| 4 |
CCM
Connective Capital Management
Palo Alto,
California
|
+$312K |
| 5 |
Jane Street
New York
|
+$284K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$961K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$410K |
| 3 |
Morgan Stanley
New York
|
-$248K |
| 4 |
JGC
J. Goldman & Co
New York
|
-$232K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$71.4K |
PYPD Hedge Fund Activity: Q2 2026 in Review
33 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in PolyPid (PYPD) for Q2 2026, worth a combined $16.7M — up 22% from $13.7M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new PYPD positions and 0 closed out — a net gain of 14 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $530K. The largest seller was Rosalind Advisors, cutting an estimated $961K.
- 33 institutional investors held PolyPid (PYPD) as of Q2 2026, up from 19 in Q1 2026.
- Funds reported $16.7M of PolyPid stock for Q2 2026, up 22% quarter-over-quarter.
- 14 funds opened new PolyPid positions in Q2 2026 and 0 closed out, a net change of +14 holders.
- The largest PolyPid buyer in Q2 2026 was Marshall Wace, an estimated $530K added.
- The largest PolyPid seller in Q2 2026 was Rosalind Advisors, an estimated $961K sold.
Based on aggregated 13F filings for Q2 2026.